A majority of state legislatures have concluded their work for 2016. The ACR’s state advocacy efforts continued to focus on policy benefiting rheumatologists and patients alike. The two dominant issues this year were biosimilar substitution and step therapy. Biosimilar Substitution Biosimilar substitution remains the most prevalent issue throughout the states. The ACR continues to monitor…
Howard Blumstein, MD, urges rheumatologists to recruit patient advocates, visit legislators, attend state society meetings
As state legislatures reconvene, the ACR is identifying states, collaborative partners to help pursue legislation
Members encouraged to advocate for rheumatology with elected officials in their home districts
The ACR expands advocacy efforts to impact state legislatures, local organizations